Prenetics Global Ltd (PRE) SEC filings

PRENasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as PRENW

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 10/30

$16.72−0.92 (-5.22%)

Close on Nov 12, 2026Market cap $282.14MP/E –Yield –

SEC filings

40 of Prenetics Global's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Current report	6-K	Nov 5, 2026	Nov 5, 2026	SEC EDGAR
Current report	6-K	Nov 3, 2026	Nov 3, 2026	SEC EDGAR
Current report	6-K	Oct 30, 2026	Nov 2, 2026	SEC EDGAR
Current report	6-K	Oct 12, 2026	Oct 13, 2026	SEC EDGAR
Annual report, amended	20-F/A	Dec 31, 2025	Sep 4, 2026	SEC EDGAR
Current report	6-K	Aug 26, 2026	Aug 26, 2026	SEC EDGAR
Current report	6-K	Aug 20, 2026	Aug 20, 2026	SEC EDGAR
Current report	6-K	Jun 30, 2026	Aug 18, 2026	SEC EDGAR
Current report	6-K	Aug 17, 2026	Aug 17, 2026	SEC EDGAR
Current report	6-K	Aug 7, 2026	Aug 7, 2026	SEC EDGAR
Annual report, amended	20-F/A	Dec 31, 2025	Jul 30, 2026	SEC EDGAR
Current report	6-K	Jul 14, 2026	Jul 14, 2026	SEC EDGAR
Annual report, amended	20-F/A	Dec 31, 2025	Jul 2, 2026	SEC EDGAR
Current report	6-K	Mar 31, 2026	Jun 10, 2026	SEC EDGAR
Current report	6-K	Jun 4, 2026	Jun 4, 2026	SEC EDGAR
Current report	6-K	May 20, 2026	May 20, 2026	SEC EDGAR
Current report	6-K	May 14, 2026	May 14, 2026	SEC EDGAR
Current report	6-K	Mar 31, 2026	May 14, 2026	SEC EDGAR
Current report	6-K	May 7, 2026	May 7, 2026	SEC EDGAR
Current report	6-K	May 4, 2026	May 4, 2026	SEC EDGAR
Annual report	20-F	Dec 31, 2025	Apr 30, 2026	SEC EDGAR
Current report	6-K	Apr 2, 2026	Apr 2, 2026	SEC EDGAR
Current report	6-K	Mar 6, 2026	Mar 6, 2026	SEC EDGAR
Current report	6-K	Mar 3, 2026	Mar 3, 2026	SEC EDGAR
Current report	6-K	Feb 18, 2026	Feb 18, 2026	SEC EDGAR
Current report	6-K	Feb 17, 2026	Feb 17, 2026	SEC EDGAR
Current report	6-K	Feb 17, 2026	Feb 17, 2026	SEC EDGAR
Current report	6-K	Jan 6, 2026	Jan 6, 2026	SEC EDGAR
Current report	6-K	Jan 5, 2026	Jan 5, 2026	SEC EDGAR
Current report	6-K	Dec 30, 2025	Dec 30, 2025	SEC EDGAR
Current report	6-K	Dec 23, 2025	Dec 23, 2025	SEC EDGAR
Current report	6-K	Dec 11, 2025	Dec 11, 2025	SEC EDGAR
Current report	6-K	Nov 24, 2025	Nov 24, 2025	SEC EDGAR
Current report	6-K	Nov 20, 2025	Nov 20, 2025	SEC EDGAR
Current report	6-K	Nov 19, 2025	Nov 19, 2025	SEC EDGAR
Current report	6-K	Nov 17, 2025	Nov 17, 2025	SEC EDGAR
Current report	6-K	Nov 13, 2025	Nov 13, 2025	SEC EDGAR
Current report	6-K	Nov 10, 2025	Nov 10, 2025	SEC EDGAR
Current report	6-K	Oct 28, 2025	Oct 28, 2025	SEC EDGAR
Current report	6-K	Oct 27, 2025	Oct 27, 2025	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Prenetics Global's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-15 reverse split on May 1, 2024
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PRE.

Compare: PRE vs LFVN · PRE vs LAB · PRE vs ZYBT · PRE vs MTEX · PRE vs MRVI

Revenue growth479.8% · median -5.7%

Gross margin52.8% · median 63.1%

Operating margin-48.1% · median -22.2%

Net margin-40.8% · median 0.6%

Company	Revenue	Growth
MRVI	$213.00M	+10.7%
LFVN	$172.14M	-24.8%
MTEX	$103.07M	-6.6%
PRE	$92.39M	+479.8%
LAB	$84.60M	-4.8%
ZYBT	–	–

Company

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
Fiscal year ends: December 31
Employees: 98
Auditor: Deloitte Touche Tohmatsu
SEC CIK: 1876431

Advertisement
300 × 250

See a number that looks wrong?